Evidence map›Paper›PMID 37480124›Full record

ArticleBMC complementary medicine and therapies2023

Authentication of milk thistle commercial products using UHPLC-QTOF-ESI + MS metabolomics and DNA metabarcoding.

Ancuța Cristina Raclariu-Manolică, Quentin Mauvisseau, Renato Paranaiba, Hugo J De Boer, Carmen Socaciu

Abstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Investigation ofPlants (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ancuța Cristina Raclariu-ManolicăStejarul Research Centre for Biological Sciences, National Institute of Research and Development for Biological Sciences, Alexandru cel Bun Street, 6, Piatra Neamț, 610004, Romania. anca_raclariu@yahoo.com.
Quentin MauvisseauNatural History Museum, University of Oslo, P.O. Box 1172, Blindern, Oslo, 0318, Norway.
Renato ParanaibaNatural Products Laboratory, School of Health Sciences, University of Brasília, Campus Universitário Darcy Ribeiro, Brasília, DF, 70910-900, 70910-900, Brazil.
Hugo J De BoerNatural History Museum, University of Oslo, P.O. Box 1172, Blindern, Oslo, 0318, Norway.
Carmen SocaciuFaculty of Food Science and Technology, University of Agricultural Sciences and Veterinary Medicine, Mănăştur Street, nr. 3-5, Cluj Napoca, 400372, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMilk thistle is one of the most popular hepatoprotectants, and is often sold in combination with other ingredients. Botanical supplements are known to be vulnerable to contamination and adulteration, and emerging technologies show promise to improve their quality control.

methodsUntargeted and semi-targeted metabolomics based on UHPLC-QTOF-ESI

resultsUntargeted metabolomics separated 217 molecules and by multivariate analysis the discrimination between the different preparations was established. The semi-targeted metabolomics focused on 63 phytochemicals, mainly silymarin flavonolignans and flavonoids, that may be considered as putative biomarkers of authenticity. All formulations contained molecules from silymarin complexes at different levels. The quantitative evaluation of silybins was done using in parallel UV spectrometry and UHPLC-QTOF-ESI

conclusionOur study emphasizes that combining spectroscopic, chromatographic, and genetic techniques bring complementary information to guarantee the quality of the botanical formulations.

Indexed as

Silybum marianumSilymarinChromatography, High Pressure LiquidDNA Barcoding, TaxonomicMetabolomicsSilymarinAuthenticationCommercial productsDNA metabarcodingMetabolomicsMilk thistleQualitySilybum marianum (L.) Gaertn

Identifiers

PMID37480124
PMCPMC10360273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.